Utah lets Doctronic’s AI renew chronic-condition prescriptions, the first US state-sanctioned AI role in prescribing
Confirmed
The takeaway
On Jan 6, 2026 Utah’s Office of Artificial Intelligence Policy announced a 12-month regulatory-mitigation agreement with the startup Doctronic.
Status
- Claim
Confirmed
- Our reporting
- High confidence
- Importance
- 3 of 5
- Last verified
- 6 October 2026
Your AI and this story
- GPT-6.2 AstraIn its training data
- Claude Opus 5.5In its training data
- Gemini 4 HydrogenIn its training data
- Grok 4.7In its training data
It happened before the cutoffs of all four assistants, so it can be in their training data.
Key facts
- Announced Jan 6, 2026 (pilot live from late Dec 2025/Jan 2026); 12-month regulatory mitigation agreement under Utah’s AI ‘sandbox’ law
- Scope: ~190 commonly used non-controlled drugs (e.g. hypertension, diabetes, thyroid); excludes controlled substances, pain and ADHD drugs, injectables and drugs needing regular lab monitoring
- Oversight: physicians review the first 250 renewals per drug class before autonomous processing; $4 per renewal during the pilot
- Doctronic claimed its system matched physicians’ plans in 99.2% of 500 urgent-care cases tested with regulators (Deseret News)
- Reported six-month data (Forbes, July 21, 2026; not read directly): the AI recommended approval in ~72% of cases, with physicians agreeing 91% of the time; it escalated ~28% itself, and physicians judged ~31% of those escalations overly cautious
- Critics: AMA CEO John Whyte (‘without physician input it also poses serious risks’) and Utah’s medical licensing board; Telehealth.org reported researchers finding security weaknesses in the pilot (details not verified)
What happened
Under the Utah AI Policy Act’s sandbox, the Office of AI Policy, led by Zach Boyd, can temporarily relax licensing rules for an AI pilot in exchange for monitoring and data-sharing. Doctronic’s agent checks a patient’s history and interactions, then approves the renewal or escalates it to a physician. Physicians first audit its decisions class by class.
Why it matters
It was the first time a US state legally allowed an AI system to make a prescribing decision. Its outcome data was used to justify Utah’s next step, Nolla Health’s AI-issued initial acne prescriptions (Oct 2026). Medical bodies continue to oppose it.
Sources
8 sources from 8 sites. Numbers match the chips in the text.
8 sources: 3 primary, 5 press
Primary
- Utah Office of AI Policy: Doctronic regulatory mitigation agreementcommerce.utah.gov, official
- Utah AI: Doctronic agreementai.utah.gov, official
- Utah Policy: Utah and Doctronic announce partnership for AI prescription renewals (state release)utahpolicy.com, official
Press
- Deseret News (Jan 6, 2026): Utah pilot puts AI in the driver seat on prescription renewalsdeseret.com, press
- Medical Economics: Utah lets AI refill chronic prescriptionsmedicaleconomics.com, press
- Forbes (Jul 21, 2026): Utah let AI start renewing prescriptions; six months in, data are revealingforbes.com, press
- Fierce Healthcare: inside Doctronic’s AI prescription refill pilotfiercehealthcare.com, press
- Telehealth.org: Utah AI prescription pilot under scrutiny after security testtelehealth.org, press
Changes
- Filed from STAT / Nolla coverage. Official pages and Forbes returned 403; scope and oversight facts from Medical Economics and Deseret News; six-month figures from search summaries of Forbes (confidence medium for those).